Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Drugs
- Nutraceutical
- Aquaculture
- Agriculture Forestry & Fishing
- Technical Know How
- Pharmaceuticals
- Cancer
- Personal Care Products
- DHA
- Food
- Disease
- Therapeutic
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27951
License Grant
The Licensee and the Canadian University, with the consent of the former Licensee, executed an agreement pursuant to which the Licensor authorized the Licensee to be substituted for the former Licensee in the License Agreement.
License Property
On May 1, 2001, the University and the Company have formalized this substitution for an exclusive, irrevocable worldwide license for the development, exploitation and marketing of the technologies and processes developed by, and belonging to, the University as part of the research it is conducting into devising an extraction and purification process for krill and/or calanus and/or crustaceans oil. The License Agreement also applies to oil extracted through this extraction process from krill and/or calanus and/or crustaceans.
Field of Use
The Licensee's OceanExtractTM is a cold extraction process that enables the extraction of Omega-3 polyunsaturated oil, protein concentrates and amino acid concentrates from marine biomasses such as krill, calanus and other crustaceans. Krill oil is extracted from the raw material, i.e. the krill, by successive immersions in organic solutions and through filtrations. The process allows them to obtain the biological benefits for high-end products currently sought after by the nutraceutical, cosmetics and pharmaceutical markets.
IPSCIO Record ID: 3941
License Grant
The Canadian Licensee strategically exploits, within its intellectual property portfolio, an exclusive, irrevocable worldwide License on a patent related to an extraction process belonging to the Canadian University. The License Agreement applies to the process of oil extracted from krill and from other marine and/or aquatic biomasses.
License Property
For a period of 24 months following any improvement and/or modification and/or enhancement by the Licensor, the Licensee has the right to enter into an exclusive License Agreement with respect to any such improvement and/or modification and/or enhancement. A marine oil extracted from Antarctic Krill (Euphausia Superba) that provides a unique blend of nutritional elements was the first product in the OPA3TM family to be developed and commercialized. Its elevated content in phospholipids, rich in omega-3 and omega-9 and antioxidants such as astaxanthin, vitamin A, vitamin E and flavonoid, offer a proprietary, safe and effective product free of preservatives with exceptional health benefits and superior stability.
IPSCIO Record ID: 6524
License Grant
Licensor hereby grants to the Company an exclusive, non-transferable license for the Term and in the Territory to Use the Licensed Intellectual Property solely within the Licensed Field and, where it relates to the development and commercialization of Licensed Products.
License Property
The Patent application regarding different “applications†for krill oil
Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport.
“Phospholipids†patent applications family
Natural marine source phosphlipids comprising flavonoids, polyunsaturated fatty acids and their applications.
“Neurological Field†means all conditions, abnormalities and/ or diseases related to cognitive function and/or affective and/or neurological systems. For the avoidance of doubt, any of these conditions, abnormalities and/or diseases may be acquired at any time in life regardless of cause including but not limited to genetics, developmental abnormalities, age, trauma or drugs. The Neurological Field may include Alzheimer Disease and/ or all cognitive impairment symptoms of the different stages of Alzheimer Disease, Attention-Deficit Hyperactivity Disorder (ADHA), Autism, Epilepsy, Trauma, Depression, Cognitive Decline, Memory Impairment and Dementia at all stages.
“Nutraceutical Products†means any Dietary Supplement or Functional Food that has proven health and medical benefits. “Dietary Supplement†means a product isolated or purified from foods that is generally sold in medicinal forms not usually associated with food; a dietary supplement is demonstrated to have a physiological benefit to maintain healthy physiological systems. “Functional Food†is similar in appearance to, or may be, conventional food, is consumed as part of a usual diet, and is demonstrated to have physiological benefits to maintain healthy physiological systems beyond basic nutritional functions.
“Nutrigenomic Products†means Nutraceuticals designed to interact with specific genes to reduce the risk of common chronic diseases by altering the expression of genes and the structure of an individual's genome.
Field of Use
“Licensed Field†means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for use in the human Neurological Field and containing a concentration of phospholipids extracted from Krill.
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.
IPSCIO Record ID: 145166
License Grant
The Company and Foundation agreed to a collaboration related to the research of aquaculture products.
License Property
Our aquaculture technology currently relies on our DHA biomass and by-products from our oil extraction process as raw material ingredients.
Aquaculture. Larval fish, crustaceans (shrimp) and mollusks (oysters and clams), like humans, require certain dietary fats such as DHA and ARA for optimal growth and health.
Docosahexaenoic acid, commonly known as DHA, and Arachidonic acid, commonly known as ARA, which many researchers believe may enhance mental and visual development in infants and play a pivotal role in brain function throughout life.
Field of Use
The collaborative research and license agreements is to develop new high value aquaculture feeds. The new enrichment feeds is based on proprietary DHA and ARA technology.
IPSCIO Record ID: 7233
License Grant
The Canadian Licensor grants the Canadian Licensee, a subsidiary, an exclusive, non-transferable license for the term and in the worldwide territory to use the Licensed Intellectual Property solely within the Licensed Field and where it relates to the development and commercialization of Licensed Products.
License Property
Licensed Field means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for used in the human cardiovascular field and containing a concentration of phospholipids extracted from Krill.
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.
Nutraceutical Products means any dietary supplement or functional food that has proven health and medical benefits. Dietary Supplement means a product isolated or purified from foods that is generally sold in medicinal forms not usually associated with food; a dietary supplement is demonstrated to have a physiological benefit to maintain healthy physiological systems. Functional Food is similar in appearance to, or may be conventional food, is consumed as part of a usual diet, and is demonstrated to have physiological benefits to maintain healthy physiological systems beyond basic nutritional functions.
Nutrigenomic Products means Nutraceuticals designed to interact with specific genes to reduce the risk of common chronic diseases by altering the expression of genes and the structure of an individual’s genome.
Field of Use
Licensed Field means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for used in the human cardiovascular field and containing a concentration of phospholipids extracted from Krill.
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.
The Licensee is a Canadian-based biopharmaceutical company dedicated in the research, development and commercialization of innovative proprietary active pharmaceutical ingredients for the management of cardiometabolic disorders, from prevention to treatment, bridging the treatment gap in lipid management.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
